Submitted by Anonymous (not verified) on 29 August 2023 - 14:51
Referral: Adakveo, crizanlizumab, Article 20 procedures, European Commission final decision, 25/05/2023, 03/08/2023, 29/08/2023
Source:
Referral: Adakveo, crizanlizumab, Article 20 procedures, European Commission final decision, 25/05/2023, 03/08/2023, 29/08/2023